Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
BioLife Solutions, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.08 | -$0.02 | -$0.05 |
| Q2 2025 | 5 | -$0.08 | $0.08 | -$0.03 |
| Q3 2025 | 3 | -$0.02 | $0.01 | -$0.01 |
| Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2026 | 1 | $0.04 | $0.04 | $0.04 |
| Q1 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q2 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q3 2027 | 1 | $0.11 | $0.11 | $0.11 |
| Q4 2027 | 1 | $0.11 | $0.11 | $0.11 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
BioLife Solutions, Inc. Earnings Date And Information
BioLife Solutions, Inc. last posted its earnings results on Thursday, August 7th, 2025. The company reported $-0.33135 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $0.31135. The company had revenue of 28.07 M for the quarter and had revenue of 82.25 M for the year. BioLife Solutions, Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -220.49. BioLife Solutions, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 2nd, 2026 based on prior year's report dates.
BioLife Solutions, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | N/A | $0.01 | N/A | $25.69 M | $28.07 M |
| 08/07/2025 | Q2 2025 | -$0.02 | -$0.33 | -0.31 | $23.71 M | $25.42 M |
| 05/08/2025 | Q1 2025 | -$0.03 | -$0.01 | 0.02 | N/A | $23.94 M |
| 03/03/2025 | Q4 2024 | -$0.06 | $0.27 | 0.33 | N/A | $-3,424,000 |
| 11/12/2024 | Q3 2024 | -$0.09 | -$0.04 | 0.05 | $25.54 M | $30.57 M |
| 08/09/2024 | Q2 2024 | N/A | -$0.45 | N/A | $23.95 M | $19.72 M |
| 05/10/2024 | Q1 2024 | N/A | -$0.22 | N/A | N/A | $18.43 M |
| 02/29/2024 | Q4 2023 | -$0.36 | -$0.30 | 0.06 | N/A | $17.39 M |
| 11/09/2023 | Q3 2023 | -$0.38 | -$0.67 | -0.29 | $33.01 M | $23.57 M |
| 08/09/2023 | Q2 2023 | N/A | -$0.23 | N/A | $43.64 M | $39.51 M |
| 05/11/2023 | Q1 2023 | N/A | -$0.32 | N/A | $42.94 M | $37.70 M |
| 03/31/2023 | Q4 2022 | N/A | -$1.15 | N/A | $43.40 M | $44.26 M |
| 11/09/2022 | Q3 2022 | -$0.18 | -$0.23 | -0.05 | $42.06 M | $40.75 M |
| 08/09/2022 | Q2 2022 | -$0.20 | -$1.72 | -1.52 | $39.17 M | $40.53 M |
| 05/10/2022 | Q1 2022 | N/A | -$0.18 | N/A | $38.21 M | $36.22 M |
| 03/31/2022 | Q4 2021 | N/A | -$0.37 | N/A | $35.81 M | $37.30 M |
| 11/15/2021 | Q3 2021 | N/A | $0.00 | N/A | $31.59 M | $33.80 M |
| 08/16/2021 | Q2 2021 | N/A | $0.20 | N/A | $27.58 M | $31.20 M |
| 05/17/2021 | Q1 2021 | N/A | -$0.03 | N/A | $16.05 M | $16.85 M |
| 03/31/2021 | Q4 2020 | N/A | -$0.06 | N/A | $13.54 M | $14.73 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioLife Solutions, Inc. Earnings: FAQ's
BioLife Solutions, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 2nd, 2026 based offlast year's report dates.
The conference call for BioLife Solutions, Inc.'s latest earnings report can be listened to online.
The conference call transcript for BioLife Solutions, Inc.'s latest earnings report can be read online.
BioLife Solutions, Inc. (:BLFS) has a recorded annual revenue of $82.25 M.
BioLife Solutions, Inc. (:BLFS) has a recorded net income of $-20,184,000.BioLife Solutions, Inc. has generated $-0.44 earnings per share over the last four quarters.
BioLife Solutions, Inc. (:BLFS) has a price-to-earnings ratio of -220.49 and price/earnings-to-growth ratio is -4.23.